Recent

% | $
Quotes you view appear here for quick access.

Compass Diversified Holdings Message Board

jan31 2 posts  |  Last Activity: Oct 26, 2015 8:42 AM Member since: May 23, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Oral Amp B

    by jan31 Oct 5, 2015 3:01 PM
    jan31 jan31 Oct 26, 2015 8:42 AM Flag

    IND in "2016" now and data from P1 pushed to 2017. The IND push is annoying, but the P1 data prediction is more realistic.

  • ICO, if they stick to their schedule, should be filing and IND for their oral Amp B soon ("in the second half of 2015). They also think P1 should be initiated in Q1 2016.

    I had missed the publication of "Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature" when it went up back in July. It's published in _Drug Development and Industrial Pharmacy_ Sept, 15.

    http://www.ncbi.nlm.nih.gov/pubmed/25170660

CODI
14.20+0.10(+0.71%)Feb 12 4:02 PMEST